3b6df65b-f107-43ac-9b32-d8a308104d95.png?sfvrsn=8a342d60_3)
The goals of patients, medical care providers, and payers (e.g., insurers, governments) should align to provide the most effective processes to diagnose and treat a patient’s health conditions. When cost enters the equation, however, friction can develop. <...
The goals of patients, medical care providers, and payers (e.g., insurers, governments) should align to provide the most effective processes to diagnose and treat a patient’s health conditions. When cost enters the equation, however, friction can develop. <... Read More
Many health insurers exclude experimental treatments without clearly defining which treatments they would consider experimental. In this Global Health Brief, RGA's Colin Weston discusses the need for clear definitions in policy language. He also explores how drugs, t...
Read More
In this Global Health Brief, RGA Middle East's Dr. Avinash Samudre provides a comprehensive overview of platelet-rich plasma (PRP), also known (albeit less commonly) as autologous conditioned plasma (ACP), platelet-rich growth factors (GFs), platelet-rich fibrin (PRF...
Read More
As the world enters year three of the COVID-19 pandemic, mortality and morbidity has changed substantially and for the better since the virus’s early days. Successful options for treatment have also been increasing, but at this point they are still few in number. RGA...
Read More
Robotic surgery (also known as robot-assisted surgery) is one of the fastest-growing specialties in surgical medicine today. In the past two decades, it has seen a steep rise in utilization, and today it is integral to several medical specialties. Ultimately, success...
Read More
Allergen-specific immunotherapies (AITs), which offer relief for some classes of allergies, are increasingly becoming a preferred treatment option. However, these treatments can be challenging to review and assess from the insurance perspective. This brief offers hel...
Read More
